Steven N. Perrin's Insider Trades & SAST Disclosures

Steven N. Perrin's most recent trade in Eledon Pharmaceuticals Inc was a trade of 243,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 10, 2025.

Share

Note

This is a custom search result for pattern Steven N. Perrin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Eledon Pharmaceuticals Inc	Steven N. Perrin	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	243,000	243,000	-		-	Stock Option (right to buy)
Eledon Pharmaceuticals Inc	Steven N. Perrin	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2025	27,000	27,000	-		-	Restricted Stock Units
Eledon Pharmaceuticals Inc	Steven N. Perrin	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Nov 2024	840,438	840,438	-		-	Stock Option (right to buy)
Eledon Pharmaceuticals Inc	Steven N. Perrin	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Jun 2024	428,148	428,148	-		-	Stock Option (right to buy)
Eledon Pharmaceuticals Inc	Steven N. Perrin	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2023	317,147	317,147	-		-	Stock Option (right to buy)
Eledon Pharmaceuticals Inc	Steven N. Perrin	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2023	155,000	155,000	-		-	Stock Option (right to buy)
Eledon Pharmaceuticals Inc	Steven N. Perrin	Director, President	Purchase of securities on an exchange or from another person at price $ 2.60 per share.	23 Nov 2022	1,000	1,000 (0%)	0%	2.6	2,597	Common Stock
Eledon Pharmaceuticals Inc	Steven N. Perrin	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2022	155,000	155,000	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades